Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis

Nucleic Acids Research

Volumn 42, Issue 22, 2014, Pages 13573-13587

  Yang, Hang Che ^a   Chuang, Jian Ying ^b   Jeng, Wen Yih ^a,c   Liu, Chia I ^b,c   Wang, Andrew H J ^c,d   Lu, Pei Jung ^e   Chang, Wen Chang ^f   Hung, Jan Jong ^a,b,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; HISTONE H3; HISTONE H3S10; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR SP1; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 RNF4; UNCLASSIFIED DRUG; DNA; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CELLULAR DISTRIBUTION; CHROMOSOME; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA BINDING; EMBRYO; ENZYME ASSAY; ENZYME SUBSTRATE; IN VITRO STUDY; ISOTHERMAL TITRATION CALORIMETRY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; WILD TYPE; X RAY CRYSTALLOGRAPHY; ANIMAL; CELL CULTURE; CHEMISTRY; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN CONFORMATION;

ANIMALS; CDC2 PROTEIN KINASE; CELLS, CULTURED; DNA; HELA CELLS; HUMANS; MICE; MITOSIS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN STABILITY; SP1 TRANSCRIPTION FACTOR;

EID: 84920443966     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1145     Document Type: Article

References (80)

1. Li, L. and Davie, J. R. (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann. Anat., 192, 275-283.
2. Chuang, J.-Y. and Hung, J.-J. (2011) Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway. Biochem. Biophys. Res. Commun., 407, 587-592.
3. Chuang, J.-Y., Wang, Y.-T., Yeh, S.-H., Liu, Y.-W., Chang, W.-C. and Hung, J.-J. (2008) Phosphorylation by c-Jun. NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol. Biol. Cell, 19, 1139-1151.
4. Han, I. and Kudlow, J. E. (1997) Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol., 17, 2550-2558.
5. Hung, J.-J., Wang, Y.-T. and Chang, W.-C. (2006) Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12 (S)-lipoxygenase gene transcription. Mol. Cell. Biol., 26, 1770-1785.
6. Tan, N. Y. and Khachigian, L. M. (2009) Sp1 phosphorylation and its regulation of gene transcription. Mol. Cell. Biol., 29, 2483-2488.
7. Wang, Y.-T., Chuang, J.-Y., Shen, M.-R., Yang, W.-B., Chang, W.-C. and Hung, J.-J. (2008) Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process. J. Mol. Biol., 380, 869-885.
8. Chang, W.-C. and Hung, J.-J. (2012) Functional role of post-translational modifications of Sp1 in tumorigenesis. J. Biomed. Sci., 19, 94.
9. Chu, S. and Ferro, T. J. (2005) Sp1: regulation of gene expression by phosphorylation. Gene, 348, 1-11.
10. Chun, R. F., Semmes, O. J., Neuveut, C. and Jeang, K. T. (1998) Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol., 72, 2615-2629.
11. Rafty, L. A. and Khachigian, L. M. (2001) Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. Nucleic Acids Res., 29, 1027-1033.
12. Rohlff, C., Ahmad, S., Borellini, F., Lei, J. and Glazer, R. I. (1997) Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase. J. Biol. Chem., 272, 21137-21141.
13. Armstrong, S. A., Barry, D. A., Leggett, R. W. and Mueller, C. R. (1997) Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem., 272, 13489-13495.
14. Abdelrahim, M., Smith, R. 3rd, Burghardt, R. and Safe, S. (2004) Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res., 64, 6740-6749.
15. Chuang, J.-Y., Wu, C.-H., Lai, M.-D., Chang, W.-C. and Hung, J.-J. (2009) Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int. J. Cancer J. Int. Cancer, 125, 2066-2076.
16. Mertens-Talcott, S. U., Chintharlapalli, S., Li, X. and Safe, S. (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res., 67, 11001-11011.
17. He, S. and Davie, J. R. (2006) Sp1 and Sp3 foci distribution throughout mitosis. J. Cell Sci., 119, 1063-1070.
18. Chuang, J.-Y., Wang, S.-A., Yang, W.-B., Yang, H.-C., Hung, C.-Y., Su, T.-P., Chang, W.-C. and Hung, J.-J. (2012) Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene, 31, 4946-4959.
19. Bao, L., Kimzey, A., Sauter, G., Sowadski, J. M., Lu, K. P. and Wang, D.-G. (2004) Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol., 164, 1727-1737.
20. Lu, K. P. and Zhou, X. Z. (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol., 8, 904-916.
21. Wulf, G. M., Ryo, A., Wulf, G. G., Lee, S. W., Niu, T., Petkova, V. and Lu, K. P. (2001) Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun. towards cyclin D1. EMBO J., 20, 3459-3472.
22. Yeh, E. S. and Means, A. R. (2007) PIN1, the cell cycle and cancer. Nat. Rev. Cancer, 7, 381-388.
23. Khanal, P., Yun, H. J., Lim, S. C., Ahn, S. G., Yoon, H. E., Kang, K. W., Hong, R. and Choi, H. S. (2011) Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells. Oncogene, 31, 3845-3856.
24. Liou, Y.-C., Zhou, X. Z. and Lu, K. P. (2011) Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci., 36, 501-514.
25. Lu, K. P., Finn, G., Lee, T. H. and Nicholson, L. K. (2007) Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol., 3, 619-629.
26. Wulf, G., Finn, G., Suizu, F. and Lu, K. P. (2005) Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol., 7, 435-441.
27. Lu, K. P., Hanes, S. D. and Hunter, T. (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature, 380, 544-547.
28. Lu, P.-J., Zhou, X. Z., Shen, M. and Lu, K. P. (1999) Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science, 283, 1325-1328.
29. Lu, P.-J., Zhou, X. Z., Liou, Y.-C., Noel, J. P. and Lu, K. P. (2002) Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem., 277, 2381-2384.
30. Ki, S. H., Lee, J.-W., Lim, S. C., Hien, T. T., Im, J. H., Oh, W. K., Lee, M. Y., Ji, Y. H., Kim, Y. G. and Kang, K. W. (2013) Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation. Br. J. Pharmacol., 168, 932-945.
31. Khanal, P., Kim, G., Yun, H. J., Cho, H.-G. and Choi, H. S. (2013) The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells. Mol. Carcinog., 52, 813-823.
32. Pan, C. Q., Liou, Y.-C. and Low, B. C. (2010) Active Mek2 as a regulatory scaffold that promotes Pin1 binding to BPGAP1 to suppress BPGAP1-induced acute Erk activation and cell migration. J. Cell Sci., 123, 903-916.
33. Buschdorf, J. P., Chew, L. L., Soh, U. J. K., Liou, Y.-C. and Low, B. C. (2008) Nerve growth factor stimulates interaction of Cayman ataxia protein BNIP-H/Caytaxin with peptidyl-prolyl isomerase Pin1 in differentiating neurons. PloS One, 3, e2686.
34. Estey, M. P., Di Ciano-Oliveira, C., Froese, C. D., Fung, K. Y. Y., Steels, J. D., Litchfield, D. W. and Trimble, W. S. (2013) Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis. J. Biol. Chem., 288, 30075-30086.
35. Guo, C., Hou, X., Dong, L., Dagostino, E., Greasley, S., Ferre, R., Marakovits, J., Johnson, M. C., Matthews, D., Mroczkowski, B. et al. (2009) Structure-based design of novel human Pin1 inhibitors (I). Bioorg. Med. Chem. Lett., 19, 5613-5616.
36. Dong, L., Marakovits, J., Hou, X., Guo, C., Greasley, S., Dagostino, E., Ferre, R., Johnson, M. C., Kraynov, E., Thomson, J. et al. (2010) Structure-based design of novel human Pin1 inhibitors (II). Bioorg. Med. Chem. Lett., 20, 2210-2214.
37. Lu, K. P., Suizu, F., Zhou, X. Z., Finn, G., Lam, P. and Wulf, G. (2006) Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol. Carcinog., 45, 397-402.
38. Rippmann, J. F., Hobbie, S., Daiber, C., Guilliard, B., Bauer, M., Birk, J., Nar, H., Garin-Chesa, P., Rettig, W. J. and Schnapp, A. (2000) Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ. Mol. Biol. J. Am. Assoc. Cancer Res., 11, 409-416.
39. Rustighi, A., Tiberi, L., Soldano, A., Napoli, M., Nuciforo, P., Rosato, A., Kaplan, F., Capobianco, A., Pece, S., Di Fiore, P. P. et al. (2009) The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol., 11, 133-142.
40. Strebhardt, K. (2010) Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov., 9, 643-660.
41. Zhang, Y., Daum, S., Wildemann, D., Zhou, X. Z., Verdecia, M. A., Bowman, M. E., Lucke, C., Hunter, T., Lu, K.-P., Fischer, G. et al. (2007) Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol., 2, 320-328.
42. Zhou, X. Z., Kops, O., Werner, A., Lu, P. J., Shen, M., Stoller, G., Küllertz, G., Stark, M., Fischer, G. and Lu, K. P. (2000) Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell, 6, 873-883.
43. Murshudov, G. N., Skubak, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. and Vagin, A. A. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr., 67, 355-367.
44. Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr., 60, 2126-2132.
45. Tyan, Y.-C., Wu, H.-Y., Su, W.-C., Chen, P.-W. and Liao, P.-C. (2005) Proteomic analysis of human pleural effusion. Proteomics, 5, 1062-1074.
46. Matsui, Y., Nakayama, Y., Okamoto, M., Fukumoto, Y. and Yamaguchi, N. (2012) Enrichment of cell populations in metaphase, anaphase, and telophase by synchronization using nocodazole and blebbistatin: A novel method suitable for examining dynamic changes in proteins during mitotic progression. Eur. J. Cell Biol., 91, 413-419.
47. Wang, Y.-T., Yang, W.-B., Chang, W.-C. and Hung, J.-J. (2011) Interplay of posttranslational modifications in Sp1 mediates Sp1 stability during cell cycle progression. J. Mol. Biol., 414, 1-14.
48. Leggett, R. W., Armstrong, S. A., Barry, D. and Mueller, C. R. (1995) Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J. Biol. Chem., 270, 25879-25884.
49. Tan, N. Y., Midgley, V. C., Kavurma, M. M., Santiago, F. S., Luo, X., Peden, R., Fahmy, R. G., Berndt, M. C., Molloy, M. P. and Khachigian, L. M. (2008) Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1. Circ. Res., 102, e38-e51.
50. Colgan, D. F., Murthy, K. G., Prives, C. and Manley, J. L. (1996) Cell-cycle related regulation of poly (A) polymerase by phosphorylation. Nature, 384, 282-285.
51. Hu, X. and Moscinski, L. C. (2011) Cdc2: a monopotent or pluripotent CDK? Cell Prolif., 44, 205-211.
52. Nigg, E. A. (1998) Polo-like kinases: positive regulators of cell division from start to finish. Curr. Opin. Cell Biol., 10, 776-783.
53. Santamaría, D., Barrière, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P., Malumbres, M. and Barbacid, M. (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature, 448, 811-815.
54. Darieva, Z., Pic-Taylor, A., Boros, J., Spanos, A., Geymonat, M., Reece, R. J., Sedgwick, S. G., Sharrocks, A. D. and Morgan, B. A. (2003) Cell cycle-regulated transcription through the FHA domain of Fkh2p and the coactivator Ndd1p. Curr. Biol. CB, 13, 1740-1745.
55. Enserink, J. M. and Kolodner, R. D. (2010) An overview of Cdk1-controlled targets and processes. Cell Div., 5, 11.
56. Pic-Taylor, A., Darieva, Z., Morgan, B. A. and Sharrocks, A. D. (2004) Regulation of cell cycle-specific gene expression through cyclin-dependent kinase-mediated phosphorylation of the forkhead transcription factor Fkh2p. Mol. Cell. Biol., 24, 10036-10046.
57. Reynolds, D., Shi, B. J., McLean, C., Katsis, F., Kemp, B. and Dalton, S. (2003) Recruitment of Thr 319-phosphorylated Ndd1p to the FHA domain of Fkh2p requires Clb kinase activity: a mechanism for CLB cluster gene activation. Genes Dev., 17, 1789-1802.
58. Trinh, A. T., Kim, S. H., Chang, H.-Y., Mastrocola, A. S. and Tibbetts, R. S. (2013) Cyclin-dependent kinase 1-dependent phosphorylation of cAMP response element-binding protein decreases chromatin occupancy. J. Biol. Chem., 288, 23765-23775.
59. Shen, M., Stukenberg, P. T., Kirschner, M. W. and Lu, K. P. (1998) The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev., 12, 706-720.
60. Endoh, K., Nishi, M., Ishiguro, H., Uemura, H., Miyagi, Y., Aoki, I., Hirano, H., Kubota, Y. and Ryo, A. (2011) Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis. The Prostate, 72, 626-637.
61. Grison, A., Mantovani, F., Comel, A., Agostoni, E., Gustincich, S., Persichetti, F. and Del Sal, G. (2011) Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin. Proc. Natl Acad. Sci. U. S. A., 108, 17979-17984.
62. Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X. et al. (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature, 440, 528-534.
63. Park, J. E., Lee, J. A., Park, S. G., Lee, D. H., Kim, S. J., Kim, H.-J., Uchida, C., Uchida, T., Park, B. C. and Cho, S. (2012) A critical step for JNK activation: isomerization by the prolyl isomerase Pin1. Cell Death Differ., 19, 153-161.
64. Poolman, T. M., Farrow, S. N., Matthews, L., Loudon, A. S. and Ray, D. W. (2013) Pin1 promotes GR transactivation by enhancing recruitment to target genes. Nucleic Acids Res., 41, 8515-8525.
65. Rajbhandari, P., Finn, G., Solodin, N. M., Singarapu, K. K., Sahu, S. C., Markley, J. L., Kadunc, K. J., Ellison-Zelski, S. J., Kariagina, A., Haslam, S. Z. et al. (2011) Regulation of ERα N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Mol. Cell. Biol., 32, 445-457.
66. Grinnell, F., Billingham, R. E. and Burgess, L. (1981) Distribution of fibronectin during wound healing in vivo. J. Invest. Dermatol., 76, 181-189.
67. Spiegelman, B. M. and Ginty, C. A. (1983) Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell, 35, 657-666.
68. Grinnell, F. (1984) Fibronectin and wound healing. J. Cell. Biochem., 26, 107-116.
69. Wu, C., Fields, A. J., Kapteijn, B. A. and McDonald, J. A. (1995) The role of alpha 4 beta 1 integrin in cell motility and fibronectin matrix assembly. J. Cell Sci., 108, 821-829.
70. Kimura, K., Kawamoto, K., Teranishi, S. and Nishida, T. (2006) Role of Rac1 in fibronectin-induced adhesion and motility of human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci., 47, 4323-4329.
71. Gaglio, T., Saredi, A. and Compton, D. A. (1995) NuMA is required for the organization of microtubules into aster-like mitotic arrays. J. Cell Biol., 131, 693-708.
72. Kotak, S., Busso, C. and Gönczy, P. (2013) NuMA phosphorylation by CDK1 couples mitotic progression with cortical dynein function. EMBO J., 32, 2517-2529.
73. Merdes, A., Ramyar, K., Vechio, J. D. and Cleveland, D. W. (1996) A complex of NuMA and cytoplasmic dynein is essential for mitotic spindle assembly. Cell, 87, 447-458.
74. Knoop, L. L. and Baker, S. J. (2000) The splicing factor U1C represses EWS/FLI-mediated transactivation. J. Biol. Chem., 275, 24865-24871.
75. Yang, L., Chansky, H. A. and Hickstein, D. D. (2000) EWS. Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J. Biol. Chem., 275, 37612-37618.
76. Zhang, D., Paley, A. J. and Childs, G. (1998) The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J. Biol. Chem., 273, 18086-18091.
77. Paronetto, M. P. (2013) Ewing sarcoma protein: a key player in human cancer. Int. J. Cell Biol., 2013, 12.
78. Nasim, M. T., Chernova, T. K., Chowdhury, H. M., Yue, B.-G. and Eperon, I. C. (2003) HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding. Hum. Mol. Genet., 12, 1337-1348.
79. Elliott, D. J. (2004) The role of potential splicing factors including RBMY, RBMX, hnRNPG-T and STAR proteins in spermatogenesis. Int. J. Androl., 27, 328-334.
80. Heinrich, B., Zhang, Z., Raitskin, O., Hiller, M., Benderska, N., Hartmann, A. M., Bracco, L., Elliott, D., Ben-Ari, S., Soreq, H. et al. (2009) Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC (A/C)-rich regions in pre-mRNA. J. Biol. Chem., 284, 14303-14315.